Implementation of a Work-Related Asthma Screening Questionnaire in Clinical Settings: Multimethods Study.

EMRs asthma barriers dissemination e-tools electronic medical records implementation knowledge translation limitations mobile phone work-related asthma

Journal

JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394

Informations de publication

Date de publication:
15 Sep 2022
Historique:
received: 23 02 2022
accepted: 10 08 2022
revised: 03 08 2022
pubmed: 15 8 2022
medline: 15 8 2022
entrez: 14 8 2022
Statut: epublish

Résumé

A work-related asthma (WRA) screening questionnaire is currently being validated for implementation in clinical settings. To minimize barriers to integrating tools into clinical practice, a discussion of strategies for the implementation of the questionnaire has begun. This study aimed to understand the benefits, feasibility, barriers, and limitations of implementing the Work-related Asthma Screening Questionnaire-Long version (WRASQ[L]) and asthma e-tools in clinical settings and propose dissemination and implementation strategies for the WRASQ(L). This study was conducted in Kingston, Ontario, Canada, from September 2019 to August 2021. A workshop and 2 questionnaires were used to understand the benefits of and barriers to implementing the questionnaire in clinical settings. An expert advisory committee was established to develop the implementation and dissemination strategies. Workshops were semistructured and used thematic qualitative analysis to identify themes that provided an understanding of the benefits and limitations of and barriers to using the WRASQ(L), and e-tools in general, in clinical settings. Workshop participants included patients and health care providers, including physicians, nurses, and asthma educators, who were implementation specialists and expert electronic medical record users. A questionnaire focusing on providers' knowledge and awareness of WRA and another focusing on WRASQ(L) feedback was administered at the workshops. Advisory committee members from relevant stakeholders met 3 times to strategize implementation opportunities. A total of 6 themes were identified in the workshop: involving and addressing patient needs, novel data collection, knowledge translation, time considerations, functional and practical barriers, and human limitations. Questionnaire responses yielded positive feedback on the utility of the WRASQ(L) in clinical settings. All participants agreed that it is an easy way of collecting information on occupational and exposure history and could prompt a discussion between the health care provider and patient on how the workplace and exposures could affect one's asthma, increase awareness of WRA in patients and providers, and increase awareness of exposures in the workplace. Implementation and dissemination strategies were generated with input from the advisory committee. Stakeholders and workshop participants consider the WRASQ(L) to be a useful tool that satisfies many provider needs in their clinical settings. Once validated, dissemination strategies will include developing educational materials that include the WRASQ(L), linking the questionnaire to stakeholder websites or e-toolkits, translation into other languages, leveraging health care and research networks, conference presentations, and peer-reviewed publications. Implementation strategies will include integration into electronic medical records; designing multifaceted interventions; and targeting nontraditional settings such as workplaces, pharmacies, and research settings. The WRASQ(L) addresses many benefits of and barriers to implementation, as identified in the workshop themes. These themes will guide future implementation and dissemination strategies, noting that human limitations identified in providers and patients will need to be overcome for successful implementation.

Sections du résumé

BACKGROUND BACKGROUND
A work-related asthma (WRA) screening questionnaire is currently being validated for implementation in clinical settings. To minimize barriers to integrating tools into clinical practice, a discussion of strategies for the implementation of the questionnaire has begun.
OBJECTIVE OBJECTIVE
This study aimed to understand the benefits, feasibility, barriers, and limitations of implementing the Work-related Asthma Screening Questionnaire-Long version (WRASQ[L]) and asthma e-tools in clinical settings and propose dissemination and implementation strategies for the WRASQ(L).
METHODS METHODS
This study was conducted in Kingston, Ontario, Canada, from September 2019 to August 2021. A workshop and 2 questionnaires were used to understand the benefits of and barriers to implementing the questionnaire in clinical settings. An expert advisory committee was established to develop the implementation and dissemination strategies. Workshops were semistructured and used thematic qualitative analysis to identify themes that provided an understanding of the benefits and limitations of and barriers to using the WRASQ(L), and e-tools in general, in clinical settings. Workshop participants included patients and health care providers, including physicians, nurses, and asthma educators, who were implementation specialists and expert electronic medical record users. A questionnaire focusing on providers' knowledge and awareness of WRA and another focusing on WRASQ(L) feedback was administered at the workshops. Advisory committee members from relevant stakeholders met 3 times to strategize implementation opportunities.
RESULTS RESULTS
A total of 6 themes were identified in the workshop: involving and addressing patient needs, novel data collection, knowledge translation, time considerations, functional and practical barriers, and human limitations. Questionnaire responses yielded positive feedback on the utility of the WRASQ(L) in clinical settings. All participants agreed that it is an easy way of collecting information on occupational and exposure history and could prompt a discussion between the health care provider and patient on how the workplace and exposures could affect one's asthma, increase awareness of WRA in patients and providers, and increase awareness of exposures in the workplace. Implementation and dissemination strategies were generated with input from the advisory committee.
CONCLUSIONS CONCLUSIONS
Stakeholders and workshop participants consider the WRASQ(L) to be a useful tool that satisfies many provider needs in their clinical settings. Once validated, dissemination strategies will include developing educational materials that include the WRASQ(L), linking the questionnaire to stakeholder websites or e-toolkits, translation into other languages, leveraging health care and research networks, conference presentations, and peer-reviewed publications. Implementation strategies will include integration into electronic medical records; designing multifaceted interventions; and targeting nontraditional settings such as workplaces, pharmacies, and research settings. The WRASQ(L) addresses many benefits of and barriers to implementation, as identified in the workshop themes. These themes will guide future implementation and dissemination strategies, noting that human limitations identified in providers and patients will need to be overcome for successful implementation.

Identifiants

pubmed: 35964327
pii: v6i9e37503
doi: 10.2196/37503
pmc: PMC9523520
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e37503

Informations de copyright

©Madison MacKinnon, Max Moloney, Emma Bullock, Alison Morra, Teresa To, Catherine Lemiere, M Diane Lougheed. Originally published in JMIR Formative Research (https://formative.jmir.org), 15.09.2022.

Références

Transl Behav Med. 2016 Dec;6(4):509-518
pubmed: 27118115
Eur Respir J. 2015 Jan;45(1):266-8
pubmed: 25359335
Arch Phys Med Rehabil. 2013 Jan;94(1 Suppl):S3-8
pubmed: 23141502
Eur Respir J. 2012 May;39(5):1220-9
pubmed: 22282546
J Healthc Risk Manag. 2020 Jul;40(1):33-43
pubmed: 32301249
Health Expect. 2017 Dec;20(6):1248-1253
pubmed: 28464430
Ont Health Technol Assess Ser. 2013 Sep 01;13(11):1-76
pubmed: 24194799
Int J Law Psychiatry. 2007 Jul-Oct;30(4-5):427-43
pubmed: 17692917
Allergy Asthma Clin Immunol. 2020 Aug 06;16:73
pubmed: 32922457
BMC Pediatr. 2018 Jun 5;18(1):186
pubmed: 29871611
J Contin Educ Health Prof. 2006 Winter;26(1):13-24
pubmed: 16557505
Respir Med. 2015 Mar;109(3):379-88
pubmed: 25657173
J Med Internet Res. 2018 Dec 18;20(12):e294
pubmed: 30563822
Support Care Cancer. 2019 Jul;27(7):2561-2567
pubmed: 30430301
J Coll Physicians Surg Pak. 2016 Aug;26(8):685-91
pubmed: 27539764
Occup Med (Lond). 2007 Jan;57(1):30-5
pubmed: 17200128
BMC Musculoskelet Disord. 2014 Jan 29;15:29
pubmed: 24476529
Adv Emerg Nurs J. 2009 Jan-Mar;31(1):44-53
pubmed: 20118853
Med Care. 2008 Dec;46(12):1257-66
pubmed: 19300316
J Asthma. 2015 May;52(4):398-406
pubmed: 25290815
Curr Opin Allergy Clin Immunol. 2013 Apr;13(2):138-44
pubmed: 23339935
Chest. 2007 Nov;132(5):1526-31
pubmed: 17890481
J Occup Environ Med. 2017 Apr;59(4):e71
pubmed: 28628061
Chest. 2008 Sep;134(3 Suppl):1S-41S
pubmed: 18779187
Implement Sci. 2016 Mar 17;11:38
pubmed: 26988000
JMIR Mhealth Uhealth. 2019 Jan 28;7(1):e10956
pubmed: 30688654
J Allergy Clin Immunol. 1993 Mar;91(3):702-9
pubmed: 8454792
Pol Arch Med Wewn. 2009 Oct;119(10):660-6
pubmed: 19847143
Arch Public Health. 2020 Jun 18;78:33
pubmed: 32566223
BMC Med. 2019 May 7;17(1):88
pubmed: 31064388
Chest. 2007 Jun;131(6):1768-75
pubmed: 17505048
JMIR Ment Health. 2021 Dec 20;8(12):e27991
pubmed: 34931992
J Asthma. 2015 Apr;52(3):279-88
pubmed: 25180965
Can J Physiol Pharmacol. 2006 Jan;84(1):1-4
pubmed: 16845884

Auteurs

Madison MacKinnon (M)

Asthma Research Unit, Kingston Health Sciences Centre, Kingston, ON, Canada.
Division of Respirology, Department of Medicine, Queen's University, Kingston, ON, Canada.

Max Moloney (M)

Asthma Research Unit, Kingston Health Sciences Centre, Kingston, ON, Canada.
Division of Respirology, Department of Medicine, Queen's University, Kingston, ON, Canada.

Emma Bullock (E)

Asthma Research Unit, Kingston Health Sciences Centre, Kingston, ON, Canada.
Division of Respirology, Department of Medicine, Queen's University, Kingston, ON, Canada.

Alison Morra (A)

Asthma Research Unit, Kingston Health Sciences Centre, Kingston, ON, Canada.
Division of Respirology, Department of Medicine, Queen's University, Kingston, ON, Canada.

Teresa To (T)

The Hospital for Sick Children, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Catherine Lemiere (C)

Department of Chest Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, ON, Canada.
Faculty of Medicine, University of Montreal, Montreal, ON, Canada.

M Diane Lougheed (MD)

Asthma Research Unit, Kingston Health Sciences Centre, Kingston, ON, Canada.
Division of Respirology, Department of Medicine, Queen's University, Kingston, ON, Canada.

Classifications MeSH